ENDO 2025 Abstract

MON-691 Oral Delivery Of A Bispecific GLP-1/GLP-2 Receptor Agonist (PG-102) Via A Robotic Pill (RT-114) Achieves Bioequivalence To Subcutaneous Injection In Canines

By Anvesh Dasari, Arvinder K. Dhalla, Leonard C. Fung, Sang-In Yang

Experiments in animalsInterventions

The paper

Anvesh Dasari, Arvinder K. Dhalla, Leonard C. Fung, Sang-In Yang

Rani Therapeutics (United States); ProGen

ENDO 2025 Abstract, 22 Oct 2025, CC BY-NC-ND

Presented at ENDO 2025

doi.org/10.1210/jendso/bvaf149.029

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes